This joint event will continue the RE(ACT) Congress series (6th edition) and IRDiRC Conference series (4th edition). It aims to bring together scientific leaders and experts and young scientists from a variety of breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research. Patients and patient organizations, who are committed to research, will also be in attendance to share their experiences and perspectives. For more information about Attendes and Program.
Due to a situation of “force majeure” and international travel policies associated with the #COVID19 outbreak, the congress is postponed.— RE(ACT) Community (@react_community) March 3, 2020
Dates will be communicated as soon as possible.
We apologize for this inconvenience.#REACTCongress #IRDiRC #EJPR pic.twitter.com/lgk8Ybi4ep
📢#REACTcongress n #IRDiRC #conference🔴 @EJPRareDiseases n @irdirc members have special rates for #registration! Standard registration closes THIS WEEK, 2/21🖊️⬇️https://t.co/ai6gdn1RSu#research #diagnosis #policy #therapies #precisionmedicine #clinicaltrials #drugdevelopment pic.twitter.com/sxnnHEO8g8— IRDiRC (@irdirc) February 17, 2020